Summit Global Investments’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
56,415
-13,586
| -19% | -$295K | 0.07% | 153 |
|
|
2025
Q1 | $1.7M | Sell |
70,001
-3,880
| -5% | -$94.1K | 0.12% | 101 |
|
|
2024
Q4 | $1.54M | Sell |
73,881
-3,411
| -4% | -$71.2K | 0.1% | 154 |
|
|
2024
Q3 | $1.54M | Buy |
77,292
+1,923
| +3% | +$38.2K | 0.1% | 162 |
|
|
2024
Q2 | $1.17M | Sell |
75,369
-11,333
| -13% | -$175K | 0.08% | 213 |
|
|
2024
Q1 | $1.38M | Sell |
86,702
-3,810
| -4% | -$60.7K | 0.1% | 151 |
|
|
2023
Q4 | $1.52M | Sell |
90,512
-6,883
| -7% | -$116K | 0.1% | 158 |
|
|
2023
Q3 | $1.14M | Buy |
97,395
+72,890
| +297% | +$852K | 0.08% | 194 |
|
|
2023
Q2 | $329K | Buy |
+24,505
| New | +$329K | 0.02% | 404 |
|
|
2021
Q4 | – | Sell |
-130,000
| Closed | -$689K | – | 554 |
|
|
2021
Q3 | $689K | Buy |
130,000
+72,500
| +126% | +$384K | 0.05% | 258 |
|
|
2021
Q2 | $331K | Buy |
+57,500
| New | +$331K | 0.02% | 441 |
|